Lenalidomide
Total Payments
$34,583
Transactions
11
Doctors
3
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $24,083 | 10 | 2 |
| 2017 | $10,500 | 1 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $19,500 | 3 | 56.4% |
| Travel and Lodging | $14,683 | 6 | 42.5% |
| Food and Beverage | $400.00 | 2 | 1.2% |
Ad
Manufacturing Companies
- Hikma Pharmaceuticals USA $24,083
- West-Ward Pharmaceuticals $10,500
Product Information
- Type Drug
- Total Payments $34,583
- Total Doctors 3
- Transactions 11
About Lenalidomide
Lenalidomide is a drug associated with $34,583 in payments to 3 healthcare providers, recorded across 11 transactions in the CMS Open Payments database. The primary manufacturer is Hikma Pharmaceuticals USA.
Payment data is available from 2017 to 2022. In 2022, $24,083 was paid across 10 transactions to 2 doctors.
The most common payment nature for Lenalidomide is "Honoraria" ($19,500, 56.4% of total).